fx-1006a
Showing 1 - 5 of 5
Transthyretin-associated Amyloidosis With Polyneuropathy Trial in Worldwide (Fx-1006A)
Completed
- Transthyretin-associated Amyloidosis With Polyneuropathy
- Fx-1006A
-
Baltimore, Maryland
- +3 more
Jan 9, 2013
Familial Amyloid Polyneuropathy, ATTR-PN Trial in Worldwide (Fx-1006A)
Completed
- Familial Amyloid Polyneuropathy
- ATTR-PN
- Fx-1006A
-
Buenos Aires, Argentina
- +10 more
Nov 16, 2012
Familial Amyloid Polyneuropathy Trial in Worldwide (Fx-1006A, Placebo)
Completed
- Familial Amyloid Polyneuropathy
- Fx-1006A
- Placebo
-
Boston, Massachusetts
- +9 more
Nov 16, 2012
Mild Hepatic Dysfunction, Moderate Hepatic Dysfunction Trial in Newton Park (Fx-1006A)
Completed
- Mild Hepatic Dysfunction
- Moderate Hepatic Dysfunction
- Fx-1006A
-
Newton Park, Port Elizabeth, South AfricaPfizer Investigational Site
Jun 21, 2011